金活醫藥集團(01110.HK)中期純利跌70.0%至985萬元
格隆匯 8 月 26日丨金活醫藥集團(01110.HK)公佈,截至2020年6月30日止6個月,公司收益為人民幣2.93億元,同比減少43.6%;毛利為人民幣1.10億元,同比減少24.4%,毛利率同比增加9.5個百份點至37.5%;公司擁有人應占溢利為人民幣985萬元,同比減少70.0%,基本每股盈利為人民幣1.60分。
期內,集團於藥品分部的銷售佔比為35.5%,約人民幣1.04億元,較去年同期下跌71.1%;保健品分部銷售佔比為14.5%,約人民幣4249.2萬元,較去年同期下跌42.5%;醫療設備分部銷售佔比為50.0%,約人民幣1.46億元,較去年同期上升72.6%。
因疫情封城,人流及物流運輸受到影響,2020年上半年集團代理和分銷藥品及保健品業務的銷售下跌超過60%。但是,醫療設備銷售錄得可觀增長,部分抵銷了藥品及保健品銷售的倒退。醫療設備銷售在2020年上半年增幅超過70%,主要是因為集團旗下醫療設備生產企業東迪欣的紅外線温度計銷售大幅提升。
展望未來,公眾的防疫意識不斷增強,市民講求衞生將成為常態,對防疫產品的需求將持續提升,東迪欣前景非常正面。疫情過後,隨着企業陸續復工復產,集團之藥品及保健品銷售預期亦會回覆正常水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.